ConductScience.org, home

Paper405343

Pseudomonas protease. Purification, partial characterization, and its effect on collagen, proteoglycan, and rabbit corneas.

Kessler E and 2 others. Invest Ophthalmol Vis Sci, 1977. Cited by 75 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pseudomonas protease. Purification, partial characterization, and its effect on collagen, proteoglycan, and rabbit corneas. Papers, record 405343. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/405343

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pseudomonas protease. Purification, partial characterization, and its effect on collagen, proteoglycan, and rabbit corneas.
PubMed
Journal
Invest Ophthalmol Vis Sci
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
75
iCite
Relative citation ratio, by iCite
2.95
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kessler EE
2Kennah HEH E
3Brown SIS I

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CollagenMajor topic
CorneaMajor topic
Peptide HydrolasesMajor topic
ProteoglycansMajor topic
Pseudomonas aeruginosaMajor topic
Animals
Corneal Ulcer
Glucuronates
Hexosamines
Humans
Hydroxyproline
Methods
Protease Inhibitors
Rabbits

Source PubMed

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.

PMIDTitleJournalYearIn PapersSource
37,870,218A Bacterial Quorum Sensing Regulated Protease Inhibits Host Immune Responses by Cleaving Death Domains of Innate Immune Adaptors.Adv Sci (Weinh)2023https://conductscience.org/library/papers/37870218PubMed
34,097,906Foundational concepts in the biology of bacterial keratitis.Exp Eye Res2021https://conductscience.org/library/papers/34097906PubMed
25,246,397A drug-repositioning screening identifies pentetic acid as a potential therapeutic agent for suppressing the elastase-mediated virulence of Pseudomonas aeruginosa.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/25246397PubMed
23,548,618Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor.Invest Ophthalmol Vis Sci2013https://conductscience.org/library/papers/23548618PubMed
23,365,719Infectious keratitis: secreted bacterial proteins that mediate corneal damage.J Ophthalmol2013https://conductscience.org/library/papers/23365719PubMed
12,545,697The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.Trans Am Ophthalmol Soc2002https://conductscience.org/library/papers/12545697PubMed
9,234,758Contribution of proteases and LasR to the virulence of Pseudomonas aeruginosa during corneal infections.Infect Immun1997https://conductscience.org/library/papers/9234758PubMed
8,224,956The role of Pseudomonas aeruginosa elastase in corneal ring abscess formation in pseudomonal keratitis.Graefes Arch Clin Exp Ophthalmol1993https://conductscience.org/library/papers/8224956PubMed
7,307,872The cornea in measles.Doc Ophthalmol1981https://conductscience.org/library/papers/7307872PubMed
7,263,073Age-related susceptibility of mice to ocular challenge with Pseudomonas aeruginosa exotoxin A.Infect Immun1981https://conductscience.org/library/papers/7263073PubMed
7,026,449Characterization of rabbit corneal damage produced by Serratia keratitis and by a serratia protease.Infect Immun1981https://conductscience.org/library/papers/7026449PubMed
6,815,099In vitro inhibition of Pseudomonas aeruginosa elastase by metal-chelating peptide derivatives.Infect Immun1982https://conductscience.org/library/papers/6815099PubMed
6,805,124Experimental Pseudomonas keratitis.Trans Am Ophthalmol Soc1981https://conductscience.org/library/papers/6805124PubMed
6,776,099Nutritional factors controlling exocellular protease production by Pseudomonas aeruginosa.J Bacteriol1980https://conductscience.org/library/papers/6776099PubMed
6,402,520Protease phenotypes of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.J Clin Microbiol1983https://conductscience.org/library/papers/6402520PubMed
6,317,657Transposon mutagenesis of Pseudomonas aeruginosa exoprotease genes.J Bacteriol1984https://conductscience.org/library/papers/6317657PubMed
3,079,727Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase.Infect Immun1986https://conductscience.org/library/papers/3079727PubMed
2,127,341Inhibition of Pseudomonas aeruginosa elastase and Pseudomonas keratitis using a thiol-based peptide.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2127341PubMed
2,110,137Purification and characterization of an active fragment of the LasA protein from Pseudomonas aeruginosa: enhancement of elastase activity.J Bacteriol1990https://conductscience.org/library/papers/2110137PubMed
1,903,770Serum antibody response to Pseudomonas aeruginosa antigens during corneal infection.Infect Immun1991https://conductscience.org/library/papers/1903770PubMed

See all 22 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/405343

GET https://conductscience.org/api/papers/v1/405343/cited_by?page=2